MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Multimodal and Agentic Simulated AI Patients for Bridging the gap in Parkinson Disease Education

    L. Okar, M. Fani (St. Louis, USA)

    Objective: To develop an AI training platform in PD counseling that utilizes real-time NLP processing, multimodal inputs/outputs, and adaptive reinforcement learning supported by immediate feedback…
  • 2025 International Congress

    Patient-Reported Satisfaction and Usability of a Virtual Home-Based Program for Fall Prevention in Parkinson’s Disease

    S. Dharmadhikari, V. Palakuzhy, Y. Kianirad, M. Afshari (Chicago, USA)

    Objective: To evaluate participant perspectives and satisfaction with a virtual home safety intervention to reduce environmental fall risks in persons with Parkinson’s disease (PwPs). Background: While…
  • 2025 International Congress

    Mechanical Peripheral Stimulation for the Treatment of Gait Disorders in Patients with Parkinson’s Disease (GONDOPARK): A Multi-centre, Double-blind, Crossover Randomized Controlled Trial

    MD. de Pandis, TC. Carlo, SP. Proietti, LL. Leonardi, MG. Gaglione, MC. Casali, LD. Di Biase, MG. Galli, MG. Goffredo, FS. Stocchi (Roma, Italy)

    Objective: The interventional clinical study GONDOPARK aims at evaluating the effects of AMPS treatment on gait speed and gait-related disorders in subjects with PD.The interventional…
  • 2025 International Congress

    The Impact of Myofascial Release using Dry Needling on Gait in Parkinson’s Disease: A Pilot Study

    A. Tahara, A. Gastaldi, A. Chinaglia, R. Monteiro, V. Tumas, P. Santiago (Ribeirão Preto, Brazil)

    Objective: The aim of this study was to analyze the length of the step during one cycle heel-to-heel and the time wasted to complete this…
  • 2025 International Congress

    Attitudes Toward Research Among Asian Americans, Native Hawaiian, and Pacific Islanders and Whites with Parkinson’s disease in Hawaii.

    E. Krening, R. Shuman, F. Gao, G. Ross, K. Thai, M. Faouzi, M. Bruno (Honolulu, USA)

    Objective: To assess Asian American (AA), Native Hawaiian and Pacific Islanders (NHPI) and White Parkinson’s disease (PD) patient’s attitudes toward research participation among the first…
  • 2025 International Congress

    Repeated Scanning Ultrasound in an Alpha-synuclein Preformed Fibril model

    V. Purrer, K. Roffey, G. Richter-Stretton, J. Song, G. Leinenga, L. Chen, E. Albornoz Balmaceda, J. Götz (St Lucia, Australia)

    Objective: To investigate the therapeutic potential of repeated scanning ultrasound (SUS)-mediated blood-brain barrier (BBB) opening in a mouse model of Parkinson’s disease (PD). Background: PD…
  • 2025 International Congress

    Theta burst transcranial ultrasound stimulation of internal globus pallidus and motor cortex in Parkinson’s disease

    YY. Lin, N. Raies, T. Grippe, A. Bhattacharya, C. Sarica, G. Darmani, R. Chen (Taoyuan City, Taiwan)

    Objective: To compared the effects of theta burst transcranial ultrasound stimulation (tbTUS) applied to M1, the GPi, and simultaneous M1 and GPi stimulation to investigate…
  • 2025 International Congress

    The Effect of Melatonin on Sleep Quality and Daytime Sleepiness in Parkinson’s Disease: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials

    A. Zrineh, R. Akwan, MM. Elsharkawy, B. Douden, W. Sleibi, M. Eldesouki (Al-Quds, State of Palestine)

    Objective: This study aims to systematically quantify the impact of melatonin on sleep quality and daytime sleepiness in individuals diagnosed with Parkinson’s disease (PD). Background:…
  • 2025 International Congress

    Subdomain-specific cognitive decline and its effect on caregiver burden in Mexican population living with Parkinson’s Disease.

    G. Martin-Mafud, A. Hernández-Medrano, E. Ramírez-Benitez, A. Cervantes-Arriaga, M. Rodríguez-Violante, D. Ulloa-Hernández, M. Velasco-Delgado (Mexico City, Mexico)

    Objective: To determine whether different subdomains of the MoCA associate with caregiver burden. Background: Caregivers improve the quality of life for Parkinson's patients (PwP), despite…
  • 2025 International Congress

    Qualitative research in advanced Parkinson’s disease: Exploring salient symptoms and suitability of the MDS-NMS from the patient, caregiver, and clinician perspective

    N. Williamson, A. Lydon, S. Wallace, E. Taylor, M. Chaudry, H. Bradley, R. Williams-Hall, P. Boccon-Gibod, K. Raphael, E. Stevens, P. Odin, A. Antonini, M. Biagioni (Bollington, United Kingdom)

    Objective: To identify which non-motor symptoms (NMS) are most relevant in an advanced Parkinson’s Disease (PD) population and determine the suitability of the International Parkinson…
  • « Previous Page
  • 1
  • …
  • 45
  • 46
  • 47
  • 48
  • 49
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley